GENEVA, Oct. 15 -- BONUM THERAPEUTICS, INC. filed a patent application (US2026/022499) for “LAG-3-REGULATABLE IL-2 RECEPTOR AGONISTS”. With publication no. WO/2026/217464, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....